Mr Peter Giannopoulos appointed as CEO of Cell Therapies Pty Ltd
Date Posted – 6 April 2021 Cell Therapies Pty Ltd, a leading provider of cell and gene therapy products in the Asia Pacific region, is delighted to announce the appointment of Mr Peter Giannopoulos as the company’s new Chief Executive…
University of Sydney receives approval to start COVALIA, a Phase 1 Clinical trial of COVIGEN, a New COVID-19 Vaccine Candidate in Australia
Date Posted – 26 March 2021 Date Published – 22 March 2021 First needle-free DNA-based COVID-19 candidate vaccine to be tested in Australia in a phase 1 trial in healthy subjects aged 18 to 75 years old •…
PI expands manufacturing facilities with new medtech wing in Melbourne
Date Posted – 26 March 2021 Australia’s Minister for Industry, Science and Technology Karen Andrews visited Planet Innovation (PI) to officially open a new 1,000m2 medtech manufacturing wing in our Melbourne facility. The new wing is part of PI’s…
CoSec Acquired by International Corporate Services Provider Acclime
Date Posted – 22 March 2021 CoSec was acquired by international corporate services provider Acclime in a strategic move by both companies to expand operations internationally. Acclime has a strong and growing presence in nine key Asian jurisdictions…
CSIRO moves towards Open Access for national benefit
Date posted – 17 March 2021 Media Release date – 3 March 2021 Research aimed at solving Australia’s greatest challenges will be made increasingly accessible as part of a shift towards ‘Open Access’ models at the national science…
ANDHealth Collaborates with US Healthcare Leader Anthem Inc. to Bring Innovative Australian Technologies to the US Market
Date posted – 17 March 2021 ANDHealth last week announced a joint effort with the Anthem Digital Incubator to facilitate and accelerate US market access and uptake for Australian digital health companies and their products and services. Anthem,…
PharmaLex broadens biopharma expertise
Date posted – 9 March 2021 The addition of ERA Consulting allows PharmaLex to further expand its geographic footprint as well as strengthens its biopharma capabilities Frankfurt, Germany – February 24, 2021: PharmaLex Group, a leading provider of…
Cartherics Announces Grant of European Patent
Date posted – 8 March 2021 First patented product to enter clinic within two years Cartherics Pty Ltd (Cartherics) announced today the grant of a European patent entitled “Genetically modified cells and uses thereof”. The patent covers aspects…
Monash University retains its spot as #2 in the world for Pharmacy and Pharmacology
Date posted – 4 March 2021 The 2021 QS World University Rankings by Subject, released today, ranked Monash University number two in the world for Pharmacy and Pharmacology for the second year running. Pharmacy and Pharmacology remains Monash’s…
ALHI $28.9M MRFF GRANT REVOLUTIONISES LUNG FUNCTION SCANNING
Date posted – 4 March 2021 The Australian Lung Health Initiative (ALHI) is pleased to announce it has been granted $28.9 million in funding from the Australian Federal Government’s Medical Research Future Fund (MRFF) Frontier Health and Medical…
Monash University and PureTech Health develop novel technology platform that targets drugs to the lymphatics and lymph nodes
Date posted – 26 February 2021 Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) and PureTech Health (LSE: PRTC, Nasdaq: PRTC) have developed a novel technology platform that directly targets gut lymphatics and has great potential to…
VivaZome and La Trobe University enter new research collaboration to develop exosome therapeutics.
16 February 2021 VivaZome Therapeutics Pty Ltd (“VivaZome”) and La Trobe University today announced that they have entered into a new collaborative research project focussed on developing novel exosome therapeutics. Under the collaborative arrangement, VivaZome scientists will work…
